News

GRID VIEW

No more posts
Alzheimers-image-10.jpg

August 11, 2022


We are conducting a clinical research study for people who have Alzheimer’s disease. This study will evaluate a new investigational drug.

You may be eligible if you:

  • Are between 60 and 85 years old
  • Are diagnosed with Alzheimer’s disease
  • Have a body mass index between 18.0 and 32.0 kg/m2
  • Are able to complete MRI and PET scans

There are additional criteria to meet to qualify for this study. For volunteers who qualify for our study, all study-related procedures, study drug, and medical exams will be provided at no cost. Qualified volunteers will also receive a stipend for time and travel. No health insurance is required to participate.

For more information call

(904) 730-0166

Or sign up below and our office will call you!



This research study is enrolling at:


Jacksonville Center for Clinical Research
4085 University Blvd., South, Suite 1
Jacksonville, FL 32216
(904) 730-0166



Learn More

If you want us to contact you about our research studies call (904) 730-0166 or sign up below!


Asthma-2.jpg

February 23, 2023


Eosinophilic asthma is a type of asthma that is characterized by high levels of eosinophils in the airways. Eosinophils are a type of white blood cell that are involved in the body’s immune response to allergens and other triggers. When eosinophils are activated, they release inflammatory chemicals that can cause damage to the airways, leading to asthma symptoms.

Symptoms of eosinophilic asthma include wheezing, coughing, shortness of breath, and chest tightness. These symptoms may be more severe than those of other types of asthma and may not respond as well to traditional asthma treatments like inhaled corticosteroids.

For more information about clinical trials call:

(904) 730-0166

Or sign up below and our office will call you!



This research study is enrolling at:


Jacksonville Center for Clinical Research
4085 University Blvd., South, Suite 1
Jacksonville, FL 32216
(904) 730-0166



Learn More

If you want us to contact you about our research studies call (904) 730-0166 or sign up below!


Atrial-Fib.jpg

October 27, 2021
Atrial Fib


    If you are interested in a research study for Atrial Fibrillation, sign up below!

    Qualified volunteers may receive at no cost:

    • investigational medication
    • study-related care from a local doctor
    • possible compensation
    Health insurance isn’t required to participate.
    Ask your doctor or contact our clinic for more information.

    • St. Augustine Study
    • Inverness Study
    St. Augustine Study

    Atrial Fibrillation

    Atrial fibrillation (a-fib) is a heart rhythm disorder characterized by irregular heartbeats in the heart’s upper chambers, called the atria. In a-fib, the electrical signals that regulate the heartbeat become abnormal, causing the heart to beat too fast or slow instead of contracting normally. Atrial fibrillation can have detrimental effects such as stroke, heart failure, and blood clots.

    We are conducting a clinical research study comparing a new oral investigational medication with apixaban for the prevention of stroke or systemic embolism in people with atrial fibrillation.

    You may be eligible if you:

    • Are 18 years or older
    • Have atrial fibrillation

    There are additional criteria to meet to qualify for this study. Volunteers who qualify for our study will receive study-related medication and medical exams at no cost, along with a stipend for time and travel. No health insurance is required to participate.

    For more information call

    (904) 209-0043

    Or sign up below, and our friendly staff will call you!

    Inverness Study

    Atrial Fibrillation

    Atrial fibrillation (a-fib) is a heart rhythm disorder characterized by irregular heartbeats in the heart’s upper chambers, called the atria. In a-fib, the electrical signals that regulate the heartbeat become abnormal, causing the heart to beat too fast or slow instead of contracting normally. Atrial fibrillation can have detrimental effects such as stroke, heart failure, and blood clots.

    We are conducting a clinical research study comparing a new oral investigational medication with apixaban for the prevention of stroke or systemic embolism in people with atrial fibrillation.

    You may be eligible if you:

    • Are 18 years or older
    • Have atrial fibrillation

    There are additional criteria to meet to qualify for this study. Volunteers who qualify for our study will receive study-related medication and medical exams at no cost, along with a stipend for time and travel. No health insurance is required to participate.

    For more information call

    (352) 341-2100

    Or sign up below, and our friendly staff will call you!



    This research study is enrolling at:


    Nature Coast Clinical Research – Inverness
    411 West Highland Boulevard
    Inverness, FL 34452
    (352) 563-1865



    St. Johns Center for Clinical Research
    100 Whetstone Place,
    Suites 300 – 301,
    St. Augustine, FL 32086

    (904) 209-0043



    BELOW ARE HIDDEN ROWS

    Fleming Island Center for Clinical Research
    1679 Eagle Harbor Parkway
    Suite D, 2nd Floor Fleming Island, FL 32003
    (904) 621-0390



    Jacksonville Center for Clinical Research
    4085 University Blvd., South
    Suite 1
    Jacksonville, FL 32216
    (904) 730-0166



    St. Johns Center for Clinical Research
    100 Whetstone Place,
    Suites 300 – 301,
    St. Augustine, FL 32086

    (904) 209-0043



    ENCORE Borland Groover Clinical Research
    4800 Belfort Road, Suite 301
    Jacksonville, FL 32256
    (904) 680-0871



    Westside Center for Clinical Research
    810 Lane Avenue South
    Jacksonville, FL 32205
    (904) 693-1490



    Nature Coast Clinical Research – Inverness
    411 West Highland Boulevard
    Inverness, FL 34452
    (352) 341-2100



    Nature Coast Clinical Research – Crystal River
    6122 West Corporate Oaks Drive
    Crystal River, FL 34429
    (352) 861-1865



    Learn More

    If you want us to contact you about our research studies call (904) 730-0166 or sign up below!


    Axial-Spondyloarthritis-Spine.jpg

    July 21, 2021
    Axial Spondyloarthritis

    Axial spondyloarthritis (Axial SpA) is a type of inflammatory arthritis that primarily affects the spine and sacroiliac joints (the joints that connect the base of the spine to the pelvis). It is a chronic condition that can cause pain, stiffness, and limited mobility in the spine and other joints.

    Axial SpA is part of a larger group of related conditions called spondyloarthritis (SpA), which also includes peripheral SpA that affects joints outside the spine. Axial SpA is further divided into two subtypes: radiographic axial spondyloarthritis (r-axSpA), which is characterized by changes visible on X-ray or MRI, and non-radiographic axial spondyloarthritis (nr-axSpA), which does not show any such changes on imaging but has similar symptoms and disease activity.

    The exact cause of Axial SpA is not fully understood, but it is thought to be related to genetic and environmental factors. There is no cure for Axial SpA, but various treatments can help manage symptoms, slow disease progression, and improve quality of life.



    This research study is enrolling at:


    Jacksonville Center for Clinical Research
    4085 University Blvd., South, Suite 1
    Jacksonville, FL 32216
    (904) 730-0166



    We do not currently have any Axial Spondyloarthritis clinical trials enrolling at our ENCORE Research Group Locations. Please visit our Enrolling Studies page to see what’s enrolling now!


    Enrolling Studies

    Learn More

    If you want us to contact you about our research studies call (904) 730-0166 or sign up below!


    C.-diff-Upset-Stomach.jpg

    January 30, 2020
    C.-diff Upset Stomach

    Clostridium difficile is a potentially deadly, spore-forming bacterium emerging as the leading cause of life-threatening, healthcare-associated infections worldwide. C. diff. toxins cause gastrointestinal disease that can lead to death. Symptoms range from mild diarrhea to life-threatening colitis and often include dehydration, abdominal pain and spasms.


    • More Information about C. Diff
    More Information about C. Diff

    Ask anyone who has had a Clostridium difficile (C. difficile, or C. diff) infection and they will probably tell you that it was one of the worst experiences of their life. Imagine the worst flu you’ve ever had but on steroids! C. diff is affectionately referred to as “deadly diarrhea” and with symptoms such as watery diarrhea 10 to 15 times a day that’s no joke! It can also come with a multitude of other symptoms such as: severe abdominal pain/cramping, rapid heart rate, fever, blood or pus in the stool, nausea, dehydration, and kidney failure.

    What is C. Diff?

    C. diff is one of the many different types of bacteria that lives in our intestines. It may sound gross but bacteria in your intestines are completely normal and you need a good balance of them to remain healthy. When something such as antibiotic use throws off the balance in your intestines C. diff may start to grow out of control and begin release toxins that attack the lining of the intestines which leads to that deadly diarrhea.

    Is C. Diff contagious?

    C. diff is contagious, so even if you were not recently on antibiotics, you can still catch C. diff by contact with a contaminated surface. Spores from C. diff bacteria come from human feces, soil, water and animal feces. These spores can also live for weeks or months outside the body.

    Who is at risk?

    C. diff is most often associated with doctor or healthcare facility visits or recent antibiotic use. There is a higher risk for adults ages 50 and over, especially those that have frequent doctor visits or have had any type of recent surgery or a hospitalization.

    What can you do to lower your risk?

    Good handwashing practices, especially after doctor or healthcare facility visits are a great start to lowering your risk of getting a C. diff infection. Another way is to take probiotics daily anytime you take an antibiotic. The reason for this is because when you take an antibiotic it not only kills off the bad bacteria, but it also kills off the good bacteria, giving C. diff a chance to thrive. Taking a probiotic, even if it’s just store bought yogurt, helps feed and rebalance your good gut bacteria. These are not foolproof, but they may help.

    A Vaccine to prevent C. Diff?

    While Handwashing and probiotics are certainly a must, researchers agree they are still not enough when it comes to preventing this life-threatening infection. Which is why we are involved in a cutting-edge research for C. Diff.



    This research study is enrolling at:


    We do not currently have any C. Diff clinical trials enrolling at our ENCORE Research Group Locations. Please visit our Enrolling Studies page to see what’s enrolling now!


    Enrolling Studies

    If you want us to contact you about our research studies call (904) 730-0166 or sign up below!